GlaxoSmithKline Consumer Healthcare = Q2 /E JUNE 2010 = RESULTS = GOOD IMPROVEMENT

GlaxoSmithKline Consumer Healthcare Limited

NSE SYMBOL :GSKCONS

Q2 (APR – JUN) OF  

CY2010 (JAN TO DEC)

RESULTS COMPARISON

GlaxoSmithKline consumer Health care Limited has declared reasonably good results for the 2^nd quarter ending June,2010. The figures are compared below with the previous or first quarter (ending March 2010) and the corresponding qtr (ending June 2009). The Q1+Q2 figures upto June 2010 are multiplied by 2 for estimating the CY2010 figures (Q1+Q2 of CY2010 Known figures x 2 = full year of 2010) and these are compared with  the full previous year of CY2009.

Net Sales  at Rs.537 cr is DOWN by 17.1% compared to previous qtr( Rs.648 Cr)  - but up by 14.6% compared to corresponding qtr (Rs.469 Cr) .Q1+Q2 is up proportionately by 23.4 % compared to CY2009 (Rs.1922 Cr).

Profit  from Operations       is Rs.95 cr – down by 31.5% from previous qtr (Rs.139 Cr) – but up by 17.8% from Corresponding Qtr (Rs.81 Cr) and Q1_Q2 is up proportionately by 41.4% compared to CY2009(Rs.331 Cr).

Net Profit for Q2 (Rs.72Cr) is down by 25.4% from previous qtr (Rs.96 Cr) – but up by a good 30% from corresponding qtr of FY2009 (Rs.55 Cr) and Q1+Q2 figures are proportionately up by 44.3% from CY2009 (Rs.233 Cr).

Basic EPS at Rs.17.06      on the face Value of Rs.10 – is down by 25.4% from previous qtr (Rs.22.86)  - but is up by 30% from corresponding qtr (Rs.13.12) . The Q1+Q2 EPS is higher proportionately by 44.2% from CY2009 EPS of Rs.55.35.

PE RATIO : On the above basis, the annual EPS for current year is likely to be around Rs.80. Current Market price is Rs.1770. on this, the PE Ratio works out to 22.12.

RESULTS IN FIGURES :

GSKCONS	Jun-10	Mar-10	dif%1	Jun-09	dif%2	CY10Jan-Dec	dif%3
Net Sales	53735	64843	-17.1	46872	14.6	192150	23.4
Other OptgIncome	1515	1561	-2.9	1681	-9.9	6255	-1.6
SIT & WIP	-1202	4952	-124	-443	171
Raw Materials	19347	18554	4.3	16267	18.9
Traded Goods	2106	2106	0	1399	50.5	6523	29.1
Employees Cost	5889	5163	14.1	5234	12.5	20070	10.1
Depreciation	928	957	-3	1053	-12	4202	-10
Other Exp	18656	20763	-10.1	16956	10	69936	12.7
Total Exp	45724	52495	-12.9	40466	13	165269	18.9
Profit .Operations	9526	13909	-31.5	8087	17.8	33136	41.4
Other Income	1291	797	62	603	114	2677	56
PB I & EI	10817	14706	-26.4	8690	24.5	35813	42.5
Interest	62	57	8.8	105	-41	427	-44
P A I B B EI	10755	14649	-26.6	8585	25.3	35386	43.6
P B T	10755	14649	-26.6	8585	25.3	35386	43.6
Tax expense	3580	5033	-28.9	3066	16.8	12108	42.3
P A T	7175	9616	-25.4	5519	30	23278	44.3
Net Profit	7175	9616	-25.4	5519	30	23278	44.3
Dividend%	-	-		-		-
Face Value.Rs	10	10	0	10	0	10
Paid Up Equity	4206	4206	0	4206	0	4206
Reserves	-	-		-		-
Basic EPS	17.06	22.86	-25.4	13.12	30	55.35	44.2
Public holding%	56.84	56.84	0	56.84	0	56.84

ANNOUNCEMENTS TO

THE EXCHANGE

02-08-2010        GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 53735 lacs for quarter ending on 30-JUN-2010 against Rs. 46872 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 7175 lacs for the quarter ending on 30-JUN-2010 against Rs. 5519 lacs for the quarter ending on 30-JUN-2009.        -

23-04-2010        GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 64843 lacs for quarter ending on 31-MAR-2010 against Rs. 53937 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 9616 lacs for the quarter ending on 31-MAR-2010 against Rs. 8389 lacs for the quarter ending on 31-MAR-2009.        -

25-01-2010        Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 25, 2010 has recommended a Final Dividend at the rate of Rs.18 per equity share of Rs.10 each. Further, the Annual General Meeting is scheduled to be held on April 23, 2010.

25-01-2010        GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the year ended on 31-DEC-2009 as follows: Net Sales of Rs. 192150 lacs for year ending on 31-DEC-2009 against Rs. 154278 lacs for the year ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 23278 lacs for the year ending on 31-DEC-2009 against Rs. 18833 lacs for the year ending on 31-DEC-2008.

*  *  *    E N D   *  *  *